At the same time, the introduction of exosomes themselves into Alzheimer’s disease models led to an improvement in cognitive functions, which was associated with an increase in BDNF levels in the brain and a decrease in oxidative stress [98]. The gene discussed is BDNF; the disease is early-onset autosomal dominant Alzheimer disease.